Notifications
Back

Pipeline


IndicationModalityEarly developmentMiddle developmentLate developmentPre-clinicalClinical I/IIClinical IIIPartnership
BRVT322CRC, PDAC, GBM, melanomaSmall molecule (Repositioning)



Pre-IND @ Jun. 2026


BRVT323CRC, PDAC, GBM, melanoma
Small molecule
(NCE)






BRVT121HCC, CRC, RCC, LUADSmall molecule
(NCE)






BRVT321CRC, RCC, GCSmall molecule
(NCE)






*CRC: Colorectal cancer, PDAC: Pancreatic ductal adenocarcinoma, GBM: Glioblastoma, HCC: Hepatocellular carcinoma, RCC: Renal cell carcinoma, LUAD: Lung Adenocarcinoma, GC: Gastric cancer, NCE: New chemical entity


DiseaseModalityStage
BRVT101HCCASOEarly
BRVT121HCCSmallMiddle
BRVT231NSCLCSmallEarly
BRVT221LC(I/O)SmallEarly
BRVT321CRCSmallEarly